title: Tumor flare reactions and response to lenalidomide in patients with refractory classic Hodgkin lymphoma.
authors.forename: Gaetano
authors.initials: G
authors.lastname: Corazzelli
authors.forename: Rosaria
authors.initials: R
authors.lastname: De Filippi
authors.forename: Gaetana
authors.initials: G
authors.lastname: Capobianco
authors.forename: Ferdinando
authors.initials: F
authors.lastname: Frigeri
authors.forename: Vincenzo
authors.initials: V
authors.lastname: De Rosa
authors.forename: Giancarla
authors.initials: G
authors.lastname: Iaccarino
authors.forename: Filippo
authors.initials: F
authors.lastname: Russo
authors.forename: Manuela
authors.initials: M
authors.lastname: Arcamone
authors.forename: Cristina
authors.initials: C
authors.lastname: Becchimanzi
authors.forename: Stefania
authors.initials: S
authors.lastname: Crisci
authors.forename: Gianpaolo
authors.initials: G
authors.lastname: Marcacci
authors.forename: Barbara
authors.initials: B
authors.lastname: Amoroso
authors.forename: Secondo
authors.initials: S
authors.lastname: Lastoria
authors.forename: Antonio
authors.initials: A
authors.lastname: Pinto
mesh_terms: D000328:Adult; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000009:adverse effects*; D057176:Compassionate Use Trials; D006689:Hodgkin Disease / Q000188:drug therapy / Q000276:immunology / Q000473:pathology*; D006801:Humans; D007249:Inflammation / Q000139:chemically induced / Q000188:drug therapy / Q000473:pathology; D000077269:Lenalidomide; D008297:Male; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy / Q000473:pathology*; D013792:Thalidomide / Q000009:adverse effects / Q000031:analogs & derivatives*; D055815:Young Adult
chemical_list: D000893:Anti-Inflammatory Agents; D000970:Antineoplastic Agents; D013792:Thalidomide; D000077269:Lenalidomide